Raju’s health requires monitoring, court informed

June 14, 2010 05:44 pm | Updated November 28, 2021 09:04 pm IST - Hyderabad

B. Ramalinga Raju, the prime accused in Satyam Computers multi-crore scam, needs continuous medical attention, a special court trying Satyam scandal cases was told on Monday.

Raju, who is accused of inflating invoices, incomes and falsified income tax returns is being treated for Hepatitis C.

The court has fixed the next hearing on June 16.

Nizam Institute of Medical Sciences (NIMS), which has been treating Raju from last September said the side effects of the drug being administered to him require constant monitoring of his condition.

The NIMS report by Dr Ajit Kumar, a gastroenterologist treating Raju, said he needed to undergo second phase of treatment involving 24 injections — once in a week if the first phase produced satisfactory results.

“If the virus remains positive, the treatment has to be stopped as chances of cure will be negligible and it will be labelled as non-responsive. If negative, another course of 24 injections are to be administered,” Dr. Kumar said in his report.

Four more injections are to be given to Raju for four weeks as part of the 24-weeks treatment. The last injection that he was given was on June 8.

The report indicated that the Hepatitis count had “markedly” reduced from 90 lakhs before treatment to 50,000 after administering of 12 doses, which was a “satisfactory” response.

However, Raju’s condition deteriorated when he developed leucopenia after 17th dose and suffered from decreased number of white blood cells. His vital counts will be rechecked after completion of 24 injections as per international guidelines.

Meanwhile, Raju’s counsel argued that cases in all the charge sheets are similar and not separable. So far the CBI has filed three charge sheets in Satyam case and is set to file the fourth one.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.